Oxidized albumin is associated with water retention and severity of disease in patients with chronic liver diseases

e-SPEN

Volumn 5, Issue 6, 2010, Pages

  Sakata, Masahiro ^a   Kawaguchi, Takumi ^a   Taniguchi, Eitaro ^a   Nakayama, Akira ^b   Ishizaki, Sonoko ^b   Sonaka, Ichiro ^b   Nakamura, Toru ^a   Itou, Minoru ^a   Oriishi, Tetsuharu ^a   Abe, Mitsuhiko ^a   Yanagimoto, Chikatoshi ^a   Koga, Hironori ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AJINOMOTO CO INC   (Japan)

Author keywords

Albumin; Bioelectrical impedance analyzer; Edema; High performance liquid chromatography; Liver disorder; Redox

Indexed keywords

OXIDIZED ALBUMIN; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; DISEASE COURSE; EDEMA; EXTRACELLULAR FLUID; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOALBUMINEMIA; IMPEDANCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; STATISTICAL ANALYSIS; TOTAL BODY WATER; WATER RETENTION;

EID: 78649448551     PISSN: 17514991     EISSN: 17514991     Source Type: Journal    
DOI: 10.1016/j.eclnm.2010.09.003     Document Type: Article

References (60)

1. Johnson A. Low levels of plasma proteins: malnutrition or inflammation?. Clin Chem Lab Med 1999, 37:91-96.
2. Anderson C., Wochos D. The utility of serum albumin values in the nutritional assessment of hospitalized patients. Mayo Clin Proc 1982, 57:181-184.
3. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan Med Bull 1990, 37:57-84.
4. Peters T.J. Serum albumin. Adv Protein Chem 1985, 37:161-245.
5. Mera K., Anraku M., Kitamura K., Nakajou K., Maruyama T., Otagiri M. The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun 2005, 334:1322-1328.
6. Sogami M., Era S., Nagaoka S., Kuwata K., Kida K., Miura K., et al. HPLC-studies on nonmercapt-mercapt conversion of human serum albumin. Int J Pept Protein Res 1985, 25:398-402.
7. Carter D., Ho J. Structure of serum albumin. Adv Protein Chem 1994, 45:153-203.
8. Beck J., Ambahera S., Yong S., Sheil M., de Jersey J., Ralph S. Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry. Anal Biochem 2004, 325:326-336.
9. Isles T., Jocelyn P. The reaction of protein thiol groups with some disulphides. Biochem J 1963, 88:84-88.
10. King T. On the sulfhydryl group of human plasma albumin. J Biol Chem 1961, 236:PC5.
11. Era S., Kuwata K., Imai H., Nakamura K., Hayashi T., Sogami M. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995, 1247:12-16.
12. Imai H., Hayashi T., Negawa T., Nakamura K., Tomida M., Koda K., et al. Strenuous exercise-induced change in redox state of human serum albumin during intensive kendo training. Jpn J Physiol 2002, 52:135-140.
13. Oettl K., Stadlbauer V., Petter F., Greilberger J., Putz-Bankuti C., Hallström S., et al. Oxidative damage of albumin in advanced liver disease. Biochim Biophys Acta 2008, 1782:469-473.
14. Watanabe A., Matsuzaki S., Moriwaki H., Suzuki K., Nishiguchi S. Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics. Nutrition 2004, 20:351-357.
15. Suzuki E., Yasuda K., Takeda N., Sakata S., Era S., Kuwata K., et al. Increased oxidized form of human serum albumin in patients with diabetes mellitus. Diabetes Res Clin Pract 1992, 18:153-158.
16. Kadota K., Yui Y., Hattori R., Murohara Y., Kawai C. Decreased sulfhydryl groups of serum albumin in coronary artery disease. Jpn Circ J 1991, 55:937-941.
17. Terawaki H., Yoshimura K., Hasegawa T., Matsuyama Y., Negawa T., Yamada K., et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004, 66:1988-1993.
18. Shaklai N., Garlick R., Bunn H. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 1984, 259:3812-3817.
19. Yamada N., Nakayama A., Kubota K., Kawakami A., Suzuki E. Structure and function changes of oxidized human serum albumin: physiological significance of the biomarker and importance of sampling conditions for accurate measurement. Rinsho Byori 2008, 56:409-415.
20. Bito R., Hino S., Baba A., Tanaka M., Watabe H., Kawabata H. Degradation of oxidative stress-induced denatured albumin in rat liver endothelial cells. Am J Physiol Cell Physiol 2005, 289:C531-C542.
21. Iwao Y., Anraku M., Hiraike M., Kawai K., Nakajou K., Kai T., et al. The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). Drug Metab Pharmacokinet 2006, 21:140-146.
22. Kawakami A., Kubota K., Yamada N., Tagami U., Takehana K., Sonaka I., et al. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions. FEBS J 2006, 273:3346-3357.
23. Schwartzkopff W., Schwartzkopff B., Wurm W., Frisius H. Physiological aspects of the role of human albumin in the treatment of chronic and acute blood loss. Dev Biol Stand 1980, 48:7-30.
24. Coward W. Serum colloidal osmotic pressure in the development of kwashiorkor and in recovery: its relationship to albumin and globulin concentrations and oedema. Br J Nutr 1975, 34:459-467.
25. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 2003, 6:79-85.
26. Ballmer P.E., Walshe D., McNurlan M.A., Watson H., Brunt P.W., Garlick P.J. Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification. Hepatology 1993, 18:292-297.
27. Rothschild M., Oratz M., Zimmon D., Schreiber S., Weiner I., Van Caneghem A. Albumin synthesis in cirrhotic subjects with ascites studied with carbonate-14C. J Clin Invest 1969, 48:344-350.
28. Weinbren I., Taggart P., Glass H. Oedema due to abnormal distribution of protein. Lancet 1965, 1:512-513.
29. Kato M. Effect of branched-chain amino acid (BCAA) enriched-nutrient mixture on albumin metabolism in cirrhotic patients. Acta Hepatol Jpn 1991, 32:692-699.
30. Golden M., Golden B., Jackson A. Albumin and nutritional oedema. Lancet 1980, 1:114-116.
31. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
32. Pirlich M., Schütz T., Ockenga J., Biering H., Gerl H., Schmidt B., et al. Improved assessment of body cell mass by segmental bioimpedance analysis in malnourished subjects and acromegaly. Clin Nutr 2003, 22:167-174.
33. Pirlich M., Schütz T., Spachos T., Ertl S., Weiss M., Lochs H., et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000, 32:1208-1215.
34. Zillikens M.C., van den Berg J.W., Wilson J.H., Rietveld T., Swart G.R. The validity of bioelectrical impedance analysis in estimating total body water in patients with cirrhosis. J Hepatol 1992, 16:59-65.
35. Hayashi T., Imai H., Kuwata K., Sogami M., Era S. The importance of sample preservation temperature for analysis of the redox state of human serum albumin. Clin Chim Acta 2002, 316:175-178.
36. Muramoto Y., Matsushita M., Irino T. Reduction of reaction differences between human mercaptalbumin and human nonmercaptalbumin measured by the bromocresol purple method. Clin Chim Acta 1999, 289:69-78.
37. Kamath P., Wiesner R., Malinchoc M., Kremers W., Therneau T., Kosberg C., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33:464-470.
38. Pugh R., Murray-Lyon I., Dawson J., Pietroni M., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-649.
39. Pemberton P.W., Smith A., Warnes T.W. Non-invasive monitoring of oxidant stress in alcoholic liver disease. Scand J Gastroenterol 2005, 40:1102-1108.
40. Fan X. Determination of lymphocyte lipid peroxide in patients with hepatitis B and its immunological significance. Zhonghua Yi Xue Za Zhi 1990, 70:608-610. 642.
41. Bhandari S., Agarwal M., Dwivedi S., Banerjee B. Monitoring oxidative stress across worsening child pugh class of cirrhosis. Indian J Med Sci 2008, 62:444-451.
42. Ichiba M., Yamada S., Ishii K., Gonda K., Murai R., Shimomura T., et al. Significance of urinary excretion of 8-hydroxy-2'-deoxyguanosine in healthy subjects and liver disease patients. Hepatogastroenterology 2007, 54:1736-1740.
43. Halliwell B., Gutteridge J. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990, 280:1-8.
44. 131I-labelled human albumin. Clin Sci 1963, 25:281-292.
45. Fukushima H., Miwa Y., Shiraki M., Gomi I., Toda K., Kuriyama S., et al. Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatol Res 2007, 37:765-770.
46. Hara N., Iwasa M., Iwata K., Miyachi H., Tanaka H., Takeo M., et al. Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites. Hepatol Res 2009, 39:1072-1079.
47. Czaja A., Wolf A., Baggenstoss A. Clinical assessment of cirrhosis in severe chronic active liver disease: specificity and sensitivity of physical and laboratory findings. Mayo Clin Proc 1980, 55:360-364.
48. Schrier R., Arroyo V., Bernardi M., Epstein M., Henriksen J., Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988, 8:1151-1157.
49. Parving H., Ranek L., Lassen N. Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver. Scand J Clin Lab Invest 1977, 37:643-648.
50. Henriksen J. Volume adaptation in chronic liver disease: on the static and dynamic location of water, salt, protein and red cells in cirrhosis. Scand J Clin Lab Invest 2004, 64:523-533.
51. Banday A., Lokhandwala M. Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension. Am J Physiol Renal Physiol 2008, 295:F698-F706.
52. Bar-Or D., Bar-Or R., Rael L., Gardner D., Slone D., Craun M. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005, 33:1638-1641.
53. Iwao Y., Anraku M., Yamasaki K., Kragh-Hansen U., Kawai K., Maruyama T., et al. Oxidation of Arg-410 promotes the elimination of human serum albumin. Biochim Biophys Acta 2006, 1764:743-749.
54. Chalasani N., Gorski J., Horlander J.S., Craven R., Hoen H., Maya J., et al. Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 2001, 12:1010-1016.
55. Inoue M., Okajima K., Itoh K., Ando Y., Watanabe N., Yasaka T., et al. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 1987, 32:198-203.
56. Gentilini P., Casini-Raggi V., Di Fiore G., Romanelli R., Buzzelli G., Pinzani M., et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999, 30:639-645.
57. Carballal S., Radi R., Kirk M., Barnes S., Freeman B., Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003, 42:9906-9914.
58. Quinlan G., Margarson M., Mumby S., Evans T., Gutteridge J. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998, 95:459-465.
59. Quinlan G., Mumby S., Martin G., Bernard G., Gutteridge J., Evans T. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004, 32:755-759.
60. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gomez J.M., et al. Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr 2004, 23:1226-1243.